Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer — Ángeles Durán (2016) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer
Shared by
Michael Karin
University of California, San Diego
p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer
Article
2016
en
Authors
+8 more
ÁD
Ángeles Durán
EH
Eloy D. Hernandez
MR
Miguel Reina‐Campos
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2004
Dominant-negative soluble PDGF-β receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis
Erawan Borkham‐Kamphorst
,
Jens Herrmann
,
Doris Stoll
,
Jens Treptau
,
Axel M. Gressner
,
Ralf Weiskirchen
Article
2023
Mouse Models for Hepatic Stellate Cell Activation and Liver Fibrosis Initiation
Yulia A. Nevzorova
,
Ralf Weiskirchen
,
Christian Liedtke
Article
2016
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Hans-Theo Schon
,
Matthias Bartneck
,
Erawan Borkham‐Kamphorst
,
Jacob Nattermann
,
Twan Lammers
,
Frank Tacke
,
Ralf Weiskirchen
Dataset
Faculty Opinions recommendation of Human antigen R contributes to hepatic stellate cell activation and liver fibrosis.
Ralf Weiskirchen
,
Jens Herrmann
Article
2008
The megalin/gp330 receptor is involved in the capability of hepatic stellate cells to bind and internalize vitamin D binding protein (Gc-globulin)
OA Gressner
,
Birgit Lahme
,
AM Gressner
,
Ralf Weiskirchen
Discussion(0)
No comments yet. Be the first to comment.